Silo Pharma to Present at Psychedelic Drug Development Conference

Clearmind Medicine Expanding IP Portfolio with New US Patent Application for...

MINDCURE Announces Financial Results for the Third Quarter of Fiscal 2023

BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare...

Algernon Pharmaceuticals Reminds Shareholders of Previously Announced Rights Offering and Approaching...

Apex Labs Granted Approval for 160 Patient Macrodose Multi-Dose Psilocybin Clinical...

Clearmind Medicine Engages Experienced Contract Research Organization to Support its First-in-Human...

Psychedelics Weekly – The Church of Psilomethoxin Controversy, Psychedelics for Long...

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Silo Pharma Commences Formulation for SPC-15 Targeting Anxiety and PTSD Stress-Related...

Load more